Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Feb 15, 2024

BUY
$36.71 - $44.15 $145,775 - $175,319
3,971 New
3,971 $165,000
Q2 2023

Jul 28, 2023

BUY
$36.71 - $44.15 $145,775 - $175,319
3,971 New
3,971 $165,000
Q4 2022

Feb 14, 2024

BUY
$35.68 - $44.71 $154,744 - $193,907
4,337 New
4,337 $179,000

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.